S-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease

M Linnebank, J Popp, Y Smulders, D Smith… - Neurodegenerative …, 2010 - karger.com
Background: Increased plasma homocysteine levels have been described as an
independent risk factor for Alzheimer's disease (AD), but the underlying pathophysiology is …

S-Adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease

M Linnebank, J Popp, Y Smulders, D Smith… - Neurodegenerative …, 2010 - zora.uzh.ch
Background: Increased plasma homocysteine levels have been described as an
independent risk factor for Alzheimer's disease (AD), but the underlying pathophysiology is …

[PDF][PDF] S-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease

M Linnebank, J Popp, A Semmler, M Farkas, L Kulic… - 2010 - academia.edu
Background: Increased plasma homocysteine levels have been described as an
independent risk factor for Alzheimer's disease (AD), but the underlying pathophysiology is …

S-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease

M Linnebank, J Popp, Y Smulders, D Smith… - Neurodegenerative …, 2010 - cir.nii.ac.jp
抄録< jats: p> Background: Increased plasma homocysteine levels have been described as
an independent risk factor for Alzheimer's disease (AD), but the underlying pathophysiology …

S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease

M Linnebank, J Popp, Y Smulders… - Neuro …, 2010 - pubmed.ncbi.nlm.nih.gov
Background Increased plasma homocysteine levels have been described as an
independent risk factor for Alzheimer's disease (AD), but the underlying pathophysiology is …

[PDF][PDF] S-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease

M Linnebank, J Popp, A Semmler, M Farkas, L Kulic… - 2010 - researchgate.net
Background: Increased plasma homocysteine levels have been described as an
independent risk factor for Alzheimer's disease (AD), but the underlying pathophysiology is …

S-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease

M Linnebank, J Popp, Y Smulders, D Smith… - Neurodegenerative …, 2010 - karger.com
Background: Increased plasma homocysteine levels have been described as an
independent risk factor for Alzheimer's disease (AD), but the underlying pathophysiology is …

[PDF][PDF] S-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease

M Linnebank, J Popp, A Semmler, M Farkas, L Kulic… - 2010 - scholar.archive.org
Background: Increased plasma homocysteine levels have been described as an
independent risk factor for Alzheimer's disease (AD), but the underlying pathophysiology is …

S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease.

M Linnebank, J Popp, Y Smulders, D Smith… - Neuro-degenerative …, 2010 - europepmc.org
Background Increased plasma homocysteine levels have been described as an
independent risk factor for Alzheimer's disease (AD), but the underlying pathophysiology is …

S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease.

M Linnebank, J Popp, Y Smulders, D Smith… - Neuro-degenerative …, 2010 - folia.unifr.ch
OBJECTIVE This single-center, cross-sectional, correlational study analyzed homocysteine
metabolism in 60 AD patients and 60 control subjects. METHODS Fasting plasma levels of …